These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19352115)
41. Xenogeneic cellular response of human lymphocytes to porcine lymphocytes and isolated porcine pancreatic islets. Heiser A; Ulrichs K; Eckstein V; Müller-Ruchholtz W Transplant Proc; 1992 Dec; 24(6):2881-2. PubMed ID: 1465982 [No Abstract] [Full Text] [Related]
42. Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells. Wang J; Jiang S; Shi H; Lin Y; Wang J; Wang X Xenotransplantation; 2008; 15(3):164-73. PubMed ID: 18611224 [TBL] [Abstract][Full Text] [Related]
43. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. del Rio ML; Buhler L; Gibbons C; Tian J; Rodriguez-Barbosa JI Transpl Int; 2008 Nov; 21(11):1015-28. PubMed ID: 18662368 [TBL] [Abstract][Full Text] [Related]
44. Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells. Tchorsh-Yutsis D; Zlotnikov Klionsky Y; Bachar-Lustig E; Aronovich A; Feine I; Shezen E; Rosen C; Bitcover R; Eventov-Friedman S; Katchman H; Zangi L; Tal O; Cohen S; Reisner Y Transplantation; 2011 Feb; 91(4):398-405. PubMed ID: 21192322 [TBL] [Abstract][Full Text] [Related]
45. Local expression of IDO, either alone or in combination with CD40Ig, IL10 or CTLA4Ig, inhibits indirect xenorejection responses. Mulley WR; Li YQ; Wee JL; Dodge N; Christiansen D; Simeonovic C; Ierino FL; Sandrin MS Xenotransplantation; 2008; 15(3):174-83. PubMed ID: 18611225 [TBL] [Abstract][Full Text] [Related]
47. Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1. Plege-Fleck A; Lieke T; Römermann D; Düvel H; Hundrieser J; Buermann A; Kraus L; Klempnauer J; Schwinzer R Xenotransplantation; 2014; 21(6):533-42. PubMed ID: 25041075 [TBL] [Abstract][Full Text] [Related]
48. The role of costimulatory molecules as targets for new immunosuppressives in transplantation. Kishimoto K; Dong VM; Sayegh MH Curr Opin Urol; 2000 Mar; 10(2):57-62. PubMed ID: 10785843 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppression of xenograft rejection in porcine kidney PK15 cells by porcine IL-18. Choi YS; Kim YK; Shim JH; Kim EM; Kang HS; Yoon DY; Muneta Y; Myung PK Exp Mol Med; 2006 Oct; 38(5):574-82. PubMed ID: 17079874 [TBL] [Abstract][Full Text] [Related]
50. New concepts of immune modulation in xenotransplantation. Satyananda V; Hara H; Ezzelarab MB; Phelps C; Ayares D; Cooper DK Transplantation; 2013 Dec; 96(11):937-45. PubMed ID: 23851935 [TBL] [Abstract][Full Text] [Related]
51. The Role of NK Cells in Pig-to-Human Xenotransplantation. Puga Yung G; Schneider MKJ; Seebach JD J Immunol Res; 2017; 2017():4627384. PubMed ID: 29410970 [TBL] [Abstract][Full Text] [Related]
52. Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation. Bothwell AL Immunol Res; 1999; 19(2-3):233-43. PubMed ID: 10493177 [TBL] [Abstract][Full Text] [Related]
53. The immunological barriers to xenotransplantation. Vadori M; Cozzi E Tissue Antigens; 2015 Oct; 86(4):239-53. PubMed ID: 26381044 [TBL] [Abstract][Full Text] [Related]
54. Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy. Sachs DH; Sykes M; Yamada K Transpl Immunol; 2009 Jun; 21(2):101-5. PubMed ID: 19059481 [TBL] [Abstract][Full Text] [Related]
55. Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes. Lee JM; Tu CF; Yang PW; Lee KH; Tsuji K; Tsai MK; Chen RJ; Hu CY; Hsieh RP; Tai HC; Chiang BL; Weng CN; Lee YC; Lee CJ Transplantation; 2002 Jan; 73(2):193-7. PubMed ID: 11821729 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation. Papageorgiou C; Albert R; Andersen E; Zurini M; Hungerford V; Floersheim P; Schreier MH Transplant Proc; 2001 May; 33(3):2263-5. PubMed ID: 11377522 [No Abstract] [Full Text] [Related]
57. Prevention of hyperacute rejection by phosphatidylinositol-anchored factor I. Yoshitatsu M; Miyagawa S; Murase A; Matsunami K; Yamada M; Sawa Y; Ohtake S; Matsuda H; Shirakura R Transplant Proc; 2000 Aug; 32(5):905-6. PubMed ID: 10936267 [No Abstract] [Full Text] [Related]
58. Therapeutic strategies for xenograft rejection. Lin SS J Card Surg; 2001; 16(5):374-82. PubMed ID: 11885768 [TBL] [Abstract][Full Text] [Related]
59. Regulatory tolerance-mediating T cells in transplantation tolerance. Sawitzki B; Lehmann M; Ritter T; Graser E; Kupiec-Weglinski JW; Volk HD Transplant Proc; 2001 May; 33(3):2092-3. PubMed ID: 11377463 [No Abstract] [Full Text] [Related]
60. Non-human primate regulatory T cells: current biology and implications for transplantation. Dons EM; Raimondi G; Cooper DK; Thomson AW Transplantation; 2010 Oct; 90(8):811-6. PubMed ID: 20671597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]